HG BIOTECH CONSULTING LTD

Follow this company
Executive Summary

HG Biotech Consulting Ltd shows a solid financial foundation with strong liquidity and positive net assets for a startup business. The company maintains healthy cash reserves and manageable liabilities, indicating good short-term financial health. Moving forward, the focus should be on expanding revenue, managing cash flow prudently, and scaling operations strategically to ensure sustainable growth.

View Full Analysis Report →

Who controls this company?

Mr Pandelakis Georgiou

Correspondence address
Flat 3, 143 Finborough Road, London, United Kingdom, SW10 9AW
Date of birth
October 1979
Notified on
2022-10-06
Nationality
British
Country of residence
United Kingdom
 
Source data
Nature of control
Owns between 25% and 50% of the company's shares
Has between 25% and 50% of the voting rights in the company

Mrs Melpomeni Kalofonou

Correspondence address
Flat 3, 143 Finborough Road, London, United Kingdom, SW10 9AW
Date of birth
December 1984
Notified on
2022-10-06
Nationality
British
Country of residence
United Kingdom
 
Source data
Nature of control
Owns between 25% and 50% of the company's shares
Has between 25% and 50% of the voting rights in the company
More Company Information
Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
    • Follow this company